A gene therapy approach that reduces muscle stiffness after spinal cord injury has been tested in an early preclinical study.
Researchers at the University of California San Diego developed a viral-based gene therapy designed to restore inhibitory signalling in the spinal cord by boosting activity in gamma-aminobutyric acid pathways, which help regulate nerve activity and muscle control.
Please visit RegMedNet for more information.